Araştırma Makalesi

Vitamin D level in Patients with Prediabetes

Cilt: 7 Sayı: 4 31 Aralık 2020
PDF İndir
TR EN

Vitamin D level in Patients with Prediabetes

Öz

Purpose Vitamin D deficiency may cause glucose intolerance, diabetes mellitus, and metabolic syndrome. However, there are conflicting data the relationship between vitamin D levels and prediabetes in the literature. Our aim in this study is to evaluate serum 25-hydroxyvitamin D levels in prediabetic patients and to determine if vitamin D deficiency or insufficiency is a factor for developing prediabetes. Material and Method: Our study included a total of 220 patients, including 85 with isolated Impaired Fasting Glucose (IFG), 50 with isolated Impaired Glucose Tolerance (IGT), and 85 with combined IFG and IGT, and 80 healthy normoglycemic individuals similar in age, gender and BMI. Results The mean vitamin D levels between the patient group diagnosed as IGT and IFG+IGT and the control group were statistically significantly different (IGT: 11.69±6.48 ng/ml vs. control group: 16.63±9.78 ng/ml, p<0.007, IFG+IGT: 13.22±7.24 ng/ml vs. control group: 16.63±9.78 ng/ml, p<0.047, respectively). Lower 25-hydroxy vitamin D levels were associated with a higher risk of IGT (OR 2.57, 95% CI 1.01-6.53, p=0.043). 25-hydroxyvitamin D levels were similar in the control and IFG groups. No significant difference was observed between the IFG and the control group (13.90±8.89 ng/ml vs. the control group: 16.63±9.78 ng/ml, p<0.158). Moreover, no significant difference was observed between the IFG, IGT, and IFG+IGT groups, either. Discussion In this study, it was observed that vitamin D insufficiency and deficiency increased the risk of IFG, IGT and combined IFG and IGT. However, this risk was significant only in impaired glucose tolerance in vitamin D deficiency.

Anahtar Kelimeler

Kaynakça

  1. 1. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379:2279-2290.
  2. 2. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose-a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005; 2:9–15.
  3. 3. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R,et al. American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-759.
  4. 4. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-314.
  5. 5. Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010; 33:344-347.
  6. 6. Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SL et al. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 2010; 91:1627-1633.
  7. 7. Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-Hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care 2013; 36(5):1361-1367.
  8. 8. Guo J, Xiao Z, Xue X, Liu X, Lu Y, Yin X et al. 25-Hydroxyvitamin D is closely related with the function of the pancreatic islet β cells. Pak J Med Sci 2013; 29(3):809-813.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Endokrinoloji

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

31 Aralık 2020

Gönderilme Tarihi

19 Eylül 2020

Kabul Tarihi

23 Kasım 2020

Yayımlandığı Sayı

Yıl 2020 Cilt: 7 Sayı: 4

Kaynak Göster

APA
Gultekin, M., Özdemir, N., Onur, E., & Hekimsoy, Z. (2020). Vitamin D level in Patients with Prediabetes. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 7(4), 538-543. https://doi.org/10.34087/cbusbed.797240
AMA
1.Gultekin M, Özdemir N, Onur E, Hekimsoy Z. Vitamin D level in Patients with Prediabetes. CBU-SBED. 2020;7(4):538-543. doi:10.34087/cbusbed.797240
Chicago
Gultekin, Mehmet, Nilüfer Özdemir, Ece Onur, ve Zeliha Hekimsoy. 2020. “Vitamin D level in Patients with Prediabetes”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7 (4): 538-43. https://doi.org/10.34087/cbusbed.797240.
EndNote
Gultekin M, Özdemir N, Onur E, Hekimsoy Z (01 Aralık 2020) Vitamin D level in Patients with Prediabetes. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7 4 538–543.
IEEE
[1]M. Gultekin, N. Özdemir, E. Onur, ve Z. Hekimsoy, “Vitamin D level in Patients with Prediabetes”, CBU-SBED, c. 7, sy 4, ss. 538–543, Ara. 2020, doi: 10.34087/cbusbed.797240.
ISNAD
Gultekin, Mehmet - Özdemir, Nilüfer - Onur, Ece - Hekimsoy, Zeliha. “Vitamin D level in Patients with Prediabetes”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7/4 (01 Aralık 2020): 538-543. https://doi.org/10.34087/cbusbed.797240.
JAMA
1.Gultekin M, Özdemir N, Onur E, Hekimsoy Z. Vitamin D level in Patients with Prediabetes. CBU-SBED. 2020;7:538–543.
MLA
Gultekin, Mehmet, vd. “Vitamin D level in Patients with Prediabetes”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, c. 7, sy 4, Aralık 2020, ss. 538-43, doi:10.34087/cbusbed.797240.
Vancouver
1.Mehmet Gultekin, Nilüfer Özdemir, Ece Onur, Zeliha Hekimsoy. Vitamin D level in Patients with Prediabetes. CBU-SBED. 01 Aralık 2020;7(4):538-43. doi:10.34087/cbusbed.797240